Fusidic acid and clindamycin resistance in MRSA infections in children
Author Information
Author(s): Katopodis George D, Grivea Ioanna N, Tsantsaridou Angeliki J, Pournaras Spyros, Petinaki Efi, Syrogiannopoulos George A
Primary Institution: University of Thessaly, Medical School
Hypothesis
The study aims to evaluate the clinical manifestations and changes in the phenotype and genotype of MRSA isolates in children with community-associated staphylococcal infections.
Conclusion
Fusidic acid and clindamycin should be used cautiously as empiric therapy in areas with high rates of infections caused by multidrug-resistant CA-MRSA isolates.
Supporting Evidence
- Of 309 children, 180 had infections due to MRSA isolates.
- 88.9% of CA-MRSA isolates were resistant to fusidic acid.
- Clindamycin resistance increased from 0% in 2003 to 31.2% in 2009 among CA-MRSA isolates.
- Multidrug-resistant CA-MRSA isolates increased significantly over the study period.
Takeaway
Doctors found that many children in Greece have infections from a type of bacteria that is hard to treat, and some common medicines don't work well anymore.
Methodology
The study reviewed medical records of children with community-associated staphylococcal infections from January 2003 to December 2009.
Limitations
The study was retrospective and lacked detailed information on maternal infection history and other family members.
Participant Demographics
Children aged 0-14 years with community-associated staphylococcal infections.
Statistical Information
P-Value
P = 0.037
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website